Ripk1tm1.1Gsk
Targeted Allele Detail
|
|
| Symbol: |
Ripk1tm1.1Gsk |
| Name: |
receptor (TNFRSF)-interacting serine-threonine kinase 1; targeted mutation 1.1, GlaxoSmithKline |
| MGI ID: |
MGI:5749467 |
| Synonyms: |
Ripk1K45A |
| Gene: |
Ripk1 Location: Chr13:34186346-34221130 bp, + strand Genetic Position: Chr13, 14.01 cM
|
| Alliance: |
Ripk1tm1.1Gsk page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:228785
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Not Applicable) |
| Mutations: |
|
Insertion, Single point mutation
|
| |
|
Mutation details: Exon 3 was replaced with a modified one in which a point mutation results in the amino acid substitution of alanine for lysine at position 45 (K45A). Flp-mediated recombination removed the FRT flanked neomycin resistance cassette with a 3' loxP site inserted downstream of the modified exon 3.
(J:228785)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Ripk1 Mutation: |
32 strains or lines available
|
|
| Original: |
J:228785 Berger SB, et al., Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol. 2014 Jun 15;192(12):5476-80 |
| All: |
27 reference(s) |
|